DrugPatentWatch Archives
Click here to return to the current data set
|
DrugPatentWatch concentrates deep knowledge on more than 6,400 small-molecule drugs and 2,300 generic ingredients from 1,700 branded and generic pharmaceutical companies and 700 suppliers, and more than 4,300 active and expired US patents and 74,000 international patents spanning 93 countries and regional patent offices. |
Tradename: AMIODARONE HYDROCHLORIDE
Summary for Tradename: AMIODARONE HYDROCHLORIDE
|
| |||||||||||
Clinical Trials for: AMIODARONE HYDROCHLORIDEMinocycline Plus Amiodarone Versus Amiodarone Alone for the Prevention of Atrial Fibrillation After Cardiac Surgery Status: Recruiting Condition: Atrial Fibrillation Effect of Prophylaxy of Amiodarone and Propranolol and Amiodarone With Propranolol in Prevention of Atrial Fibrillation Post Coronary Artery Bypass Graft Status: Completed Condition: Atrial Fibrillation Withdrawal Versus Continuation of Amiodarone in Successfully Treated Patients With Persistent Atrial Fibrillation Status: Completed Condition: Persistent Atrial Fibrillation Catheter Ablation Versus Amiodarone for Shock Prophylaxis in Defibrillator Patients With Ventricular Tachycardia Status: Terminated Condition: Defibrillators, Implantable; Tachycardia, Ventricular Amiodarone for the Prevention of Reperfusion Ventricular Fibrillation Status: Completed Condition: Other Intraoperative Cardiac Functional Disturbances During Cardiac Surgery Safety and Efficacy of Oral Versus Intravenous Amiodarone in the Treatment of AF Status: Not yet recruiting Condition: Atrial Fibrillation Concentrations of Amiodarone in Fat Tissue During Chronic Treatment Status: Completed Condition: Arrhythmia; Atrial Fibrillation; Atrial Flutter A Phase III Superiority Study of Vernakalant vs Amiodarone in Subjects With Recent Onset Atrial Fibrillation Status: Completed Condition: Atrial Fibrillation Amiodarone Against ICD Therapy in Chagas Cardiomyopathy for Primary Prevention of Death Status: Not yet recruiting Condition: Chagas Cardiomyopathy; Non-sustained Ventricular Tachycardia; At Least 10 Points in Rassi Risk Score for Death Effect of Amiodarone on the Procedure Outcome in Long-standing Persistent Atrial Fibrillation Undergoing Pulmonary Vein Antral Isolation Status: Recruiting Condition: Atrial Fibrillation Courtesy of ClinicalTrials.org See more clinical trials for this drug | ||||||||||||
Glossary
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Type | RLD | Patent No. | Patent Expiration | Exclusivity Expiration | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Zydus Pharms Usa Inc | AMIODARONE HYDROCHLORIDE | amiodarone hydrochloride | TABLET; ORAL | 079029 | Sep 16, 2008 | RX | No | <disabled> | <disabled> | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Wockhardt | AMIODARONE HYDROCHLORIDE | amiodarone hydrochloride | INJECTABLE; INJECTION | 077610 | Oct 30, 2008 | RX | No | <disabled> | <disabled> | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Wockhardt | AMIODARONE HYDROCHLORIDE | amiodarone hydrochloride | INJECTABLE; INJECTION | 077834 | Oct 30, 2008 | RX | No | <disabled> | <disabled> | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Teva Pharms | AMIODARONE HYDROCHLORIDE | amiodarone hydrochloride | TABLET; ORAL | 074739 | Nov 30, 1998 | RX | No | <disabled> | <disabled> | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| The preview shows a limited data set. Complete access is available with a Subscription | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Export unavailable in trial.
Subscribe for complete access.
« Back to Dashboard
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Connect with Social Media:
Copyright © 2002-2013 thinkBiotech LLC. ISSN: 2162-2639
`abc